Blog - Page 3377 of 5746

TuesdayNov 15, 2011 9:17 am

Winner Medical Group (WWIN) Reports Preliminary Fourth Quarter Results

Yesterday, Winner Medical Group Inc., a China-based exporter and retailer of high-quality medical dressings and consumer products, reported preliminary unaudited consolidated financial results for the fourth quarter that ended on September 30th, 2011. These selected results are unaudited and subject to change. Compared to last year’s results, Winner’s revenues increased by 46.7% to $41.4 million. Gross profit increased by 21.2% to $10.7 million, up from $8.8 million in the same period of the prior fiscal year. Additionally, gross margin decreased to 25.8% and net income decreased by 14.5% to $2.7 million. Basic and diluted net income-per-share were both $0.11 for…

MondayNov 14, 2011 5:26 pm

U.S. Rare Earths, Inc. (UREE) Begins Drilling in Colorado for Rare Earth Elements

U.S. Rare Earths, Inc., an Arkansas-based mineral exploration, mining and claims acquisition company, today announced the start of a drilling program in one of its new areas, the Powderhorn Properties, located in Gunnison County Colorado in search of rare earth elements. The drilling follows a geologic evaluation and grab samples that were executed this summer. In a 2010 Critical Materials study conducted by the Department of Energy, Rare Earths Inc.'s holdings were found to have high concentrations of rare earth elements and the cerium-group rare earth elements that have critical national security applications as well commercial uses. “U.S. Rare Earths’…

MondayNov 14, 2011 4:15 pm

BrainStorm Cell Therapeutics, Inc. (BCLI) Study Offers Hope for ALS Patients

BrainStorm Cell Therapeutics, Inc. announced that an influx of patients from around the world are requesting to be included in studies targeting ALS therapy at Hadassah University Medical Center in Jerusalem. ALS, or Lou Gehrig's Disease, affects nerve cells in the brain and spinal cord, and potentially effects as many as 30,000 Americans, and 750 Israeli citizens. BrainStorm is a biotech company that focuses on the treatment of neurodegenerative diseases, such as ALS. Their main technology is based around adult stem cell therapy products that are obtained through autologous bone marrow cells; that is, cells that are taken from a…

MondayNov 14, 2011 3:55 pm

EMRISE (EMRI) Posts Improvements in Q3 2011 Financial Performance

EMRISE Corp., a multi-national manufacturer of defense, aerospace and industrial electronic devices and communications equipment, today posted its financial results for the third quarter ended September 30, 2011. The company reported third quarter 2011 net sales of $9.1 million, a 16 percent increase compared to net sales from continuing operations of $7.8 million in the third quarter of 2010. Net income for the third quarter of 2011 was $14,000, or $0.00 per basic and diluted share, compared to a net loss of $1.1 million, or $0.11 loss per basic and diluted share, reported in the third quarter of 2010. Overall…

MondayNov 14, 2011 12:55 pm

Strategic American Oil Corp. (SGCA) Takes Advantage of New Oil Dynamic

In all of your life, do you ever remember a time when experts weren’t warning that the world is rapidly running out of oil? It was an easy call, since oil, like any non-renewable resource, is finite, while oil usage continues to grow with industrialization. The fact is that oil has yet to be economically replaced, and, government programs aside, money still tends to rule. The idea that we’ll wake up one day and all of the oil will be gone fails to consider that critical dynamic. Oil doesn’t run out, it just gets tougher and tougher to find and…

MondayNov 14, 2011 12:04 pm

Caduceus Software Systems Corp. (CSOC) Delivers Details on Caduceus MMS Software Platform, Revealing a Full-Spectrum Suite of Tools and Extremely Intuitive Design

Caduceus, widely known in patient care circles around the world as a consistent innovator in full-spectrum software platform solutions for doctors and private practitioners to meet their healthcare information management needs, recently responded to mounting demand from shareholders/end-users to divulge more information about the Company’s revolutionary Healthcare Information Systems Software platform. The Caduceus MMS Software platform was engineered from the ground up to represent an entirely new breed of HER/EMB solution (electronic health record and medical billing). The broad market potential of the Caduceus MMS platform, with its suite of professional-grade data management tools, is underscored by unique additions like…

MondayNov 14, 2011 11:32 am

European Approval of Stevia Opens New Opportunities for GLG Life Tech Corp. (GLGL)

GLG Life Tech is a global leader in the supply of high purity stevia extracts – an all-natural, zero calorie sweetener used in food and beverages. The company's operations cover each step in the supply chain, from the stevia plant to marketing and distribution of the finished product. The company announced today that the European Parliament and the Council of Ministers have formally adopted the regulation to allow the use of steviol glycosides in the European Union this year. The regulation will take effect 20 days after it is published in the EU Official Journal. This decision means that consumers…

MondayNov 14, 2011 11:23 am

Searchlight Minerals Corp. (SRCH) Video Chart for Monday, November 14, 2011

SRCH made a huge climb in August and September. Since the peak at $1.54, the share value has retraced to a strong support level at $0.72. Technical traders will be watching for the support to continue to hold and a potential push towards the first resistance at 90 cents. To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts Let us hear your thoughts below:

MondayNov 14, 2011 10:46 am

YM BioSciences Inc. (YMI) Reports Financial and Operational Results

YM BioSciences, Inc., an Ontario based drug development company advancing a diverse portfolio of hematology and cancer-related products, today reported results of its first fiscal quarter of 2012 ending September 30, 2011. The company trimmed its net loss to $900,000 compared to a loss of $11.3 million in the same quarter last year. Revenue from out-licensing was unchanged and the company saw a gain of $5.4 million on the revaluation of warrants compared with a loss of $3.4 million in the prior year’s first quarter. YM BioSciences Inc. is advancing three main drug products: CYT387, a small molecule, dual inhibitor…

FridayNov 11, 2011 4:48 pm

China Pharma Holdings, Inc. (CPHI) Posts Q3 Financial Results, 12% Rev Increase

China Pharma Holdings Inc., a specialty pharmaceuticals company in China, today announced its financial results for the quarter ended September 30, 2011. The company reported a 12 percent increase in third quarter 2011 revenue to $21.0 million compared to $18.7 million in the comparable quarter of 2010. Net income for the third quarter of 2011 was $3.3 million, or $0.08 per basic and diluted share, compared to $5.9 million, or $0.14 per basic and diluted share, in the third quarter of 2010. China Pharma reported operating income of $3.9 million in the third quarter of 2011, down 37 percent from…

Site Search

Company Search